دورية أكاديمية
أعرض في EDS

Endothelial dysfunction and cardiovascular diseases in people living with HIV on specific highly active antiretroviral therapy regimen: A systematic review of clinical studies.

التفاصيل البيبلوغرافية
العنوان: Endothelial dysfunction and cardiovascular diseases in people living with HIV on specific highly active antiretroviral therapy regimen: A systematic review of clinical studies.
المؤلفون: Mokoena H; Department of Physiology and Environmental Health, University of Limpopo, Sovenga, 0727, South Africa., Mabhida SE; Non-Communicable Diseases Research Unit, South African Medical Research Council, Tygerberg, 7505, South Africa., Choshi J; Department of Physiology and Environmental Health, University of Limpopo, Sovenga, 0727, South Africa., Dludla PV; Cochrane South Africa, South African Medical Research Council, Tygerberg, 7505, South Africa.; Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa, 3880, South Africa., Nkambule BB; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa., Mchiza ZJ; Non-Communicable Diseases Research Unit, South African Medical Research Council, Tygerberg, 7505, South Africa.; School of Public Health, University of the Western Cape, Bellville, 7535, South Africa., Ndwandwe DE; Cochrane South Africa, South African Medical Research Council, Tygerberg, 7505, South Africa., Kengne AP; Non-Communicable Diseases Research Unit, South African Medical Research Council, Tygerberg, 7505, South Africa.; Department of Medicine, University of Cape Town, Cape Town, 7700, South Africa., Hanser S; Department of Physiology and Environmental Health, University of Limpopo, Sovenga, 0727, South Africa.
المصدر: Atherosclerosis plus [Atheroscler Plus] 2024 Feb 05; Vol. 55, pp. 47-54. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918249514806676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-0895 (Electronic) Linking ISSN: 26670895 NLM ISO Abbreviation: Atheroscler Plus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Amsterdam] : Elsevier B.V., [2021]-
مستخلص: Despite the improved efficacy of highly active antiretroviral therapy (HAART) in viral suppression, emerging evidence indicates an increased burden of noncommunicable diseases in people living with HIV (PLWH). Immune activation and persistently elevated levels of inflammation have been associated with endothelial dysfunction in PLWH, likely contributing to the development of cardiovascular diseases (CVDs). Here, electronic search databases including PubMed, Google Scholar, Cochrane Library, and Science Direct were used to retrieve scientific evidence reporting on any association between markers of endothelial function and CVD-related outcomes in PLWH on HAART. Extracted data was subjected to quality assessment using the Downs and Black checklist. Most (60 %) of the results indicated the presence of endothelial dysfunction in PLWH on HAART, and this was mainly through reduced flow mediated dilation and elevated serum makers of adhesion molecules like ICAM-1, VCAM-1, and P-selectin. The summarized evidence indicates an association between persistently elevated markers of endothelial dysfunction and a pro-inflammatory state in PLWH on HAART. Only a few studies reported on improved endothelial function markers in PLWH on HAART, while limited evidence is available to prove that endothelial dysfunction is associated with CVD-risk, which could be attributed to therapeutic effects of HAART. Limited studies with relatively high quality of evidence were included in this systematic review. In conclusion, results from this review lay an important foundation for future research, even a meta-analysis, that will improve the understanding of the contributing factors to the burden of CVDs in PLWH on HAART.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2024 The Authors.)
References: Front Cardiovasc Med. 2018 Dec 19;5:185. (PMID: 30619892)
Science. 1983 May 20;220(4599):868-71. (PMID: 6189183)
Autoimmun Rev. 2008 Jul;7(7):558-66. (PMID: 18625445)
JACC Basic Transl Sci. 2022 Jan 19;7(4):410-421. (PMID: 35540101)
Vascul Pharmacol. 2019 Oct;121:106577. (PMID: 31284000)
Clin Infect Dis. 2006 May 1;42(9):1325-32. (PMID: 16586393)
J Am Coll Cardiol. 2008 Aug 12;52(7):569-76. (PMID: 18687253)
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e500-e514. (PMID: 34597384)
Front Cardiovasc Med. 2020 Jun 11;7:95. (PMID: 32596261)
Biomed Pharmacother. 2022 Feb;146:112579. (PMID: 35062054)
BMC Nutr. 2022 May 16;8(1):47. (PMID: 35578358)
AIDS. 2010 Mar 27;24(6):885-90. (PMID: 19952712)
AIDS Rev. 2020 Oct 26;23(1):1-12. (PMID: 33105472)
BMC Infect Dis. 2017 Jan 7;17(1):41. (PMID: 28061822)
Front Pharmacol. 2020 Jan 21;10:1568. (PMID: 32038245)
Curr Probl Cardiol. 2023 Sep;48(9):101783. (PMID: 37172874)
Mitochondrion. 2023 May;70:31-40. (PMID: 36925028)
BMC Infect Dis. 2013 Jun 07;13:269. (PMID: 23741991)
J Clin Med. 2021 Jan 20;10(3):. (PMID: 33498530)
Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):175-191. (PMID: 36453273)
AIDS. 2023 Feb 1;37(2):271-277. (PMID: 36541639)
Cardiovasc J Afr. 2018 May/Jun 23;29(3):155-161. (PMID: 29771268)
Circulation. 1997 Dec 16;96(12):4219-25. (PMID: 9416885)
BMC Res Notes. 2015 Jun 06;8:224. (PMID: 26048813)
AIDS. 2009 May 15;23(8):929-39. (PMID: 19425222)
Viruses. 2019 Feb 27;11(3):. (PMID: 30818749)
J Hypertens. 2020 Sep;38(9):1659-1668. (PMID: 32371769)
Clin Infect Dis. 2006 May 15;42(10):1488-95. (PMID: 16619164)
Heart. 2009 Mar;95(5):385-90. (PMID: 18653575)
J Mol Cell Cardiol. 2022 Jul;168:58-67. (PMID: 35460762)
Atherosclerosis. 2022 Jul;353:28-29. (PMID: 35710494)
Oxid Med Cell Longev. 2019 Jun 23;2019:7092151. (PMID: 31341533)
J Immunol Res. 2021 Sep 29;2021:7316456. (PMID: 34631899)
J Am Heart Assoc. 2020 Dec;9(23):e017645. (PMID: 33222591)
BMC Med. 2020 Nov 18;18(1):357. (PMID: 33203400)
Cardiovasc J Afr. 2022 Jan-Feb 23;33(1):15-20. (PMID: 34378631)
FEBS J. 2019 Apr;286(7):1256-1270. (PMID: 30220106)
J Acquir Immune Defic Syndr. 2022 Jun 1;90(2):201-207. (PMID: 35131972)
Front Med Technol. 2022 Apr 07;4:846065. (PMID: 35463298)
Circulation. 2001 Jul 17;104(3):257-62. (PMID: 11457741)
Nucl Med Commun. 2010 Oct;31(10):874-80. (PMID: 20700067)
J Antimicrob Chemother. 2016 Feb;71(2):490-6. (PMID: 26568566)
فهرسة مساهمة: Keywords: Cardiovascular disease risk; Endothelial dysfunction; Endothelial function tests; Endothelial makers; Highly active antiretroviral therapy; Human immunodeficiency virus; Inflammation; Inflammatory markers; Markers of oxidative stress
تواريخ الأحداث: Date Created: 20240221 Latest Revision: 20240222
رمز التحديث: 20240222
مُعرف محوري في PubMed: PMC10876676
DOI: 10.1016/j.athplu.2024.01.003
PMID: 38379882
قاعدة البيانات: MEDLINE
الوصف
تدمد:2667-0895
DOI:10.1016/j.athplu.2024.01.003